It seems that a fight is looming over a seat on Echo Therapeutics Inc.'s board of directors. The company's largest shareholder, an investor group led by Platinum Management (NY), LLC, which owns approximately 19.9% of Echo's common ...
Echo Therapeutics’ Symphony CGM system has won Medical Devices Business Review’s Medical Device Innovation Award. Echo's device was selected from four nominations shortlisted for the award. Symphony CGM system is a ...
Tags: Medical Device, Medicine
Echo Therapeutics, a medical device company developing its Symphony CGM system as a non-invasive, wireless continuous glucose monitoring system, has entered into a strategic collaboration agreement with Medical Technologies Innovation Asia ...
Echo Therapeutics, a medical device company, has reported positive results from its clinical trial of the Symphony CGM wireless continuous glucose monitoring system in surgical patients in hospital critical care units. Echo Therapeutics ...
Echo Therapeutics, a developer of needle-free Symphony transdermal continuous glucose monitoring (CGM) system, has obtained ISO 13485:2003 certification for its quality management system. Symphony transdermal CGM system provides accurate, ...
Tags: Echo Therapeutics, quality management system, ISO certification
The US Patent and Trademark Office (USPTO) has granted patent no. 8,386,027 to Echo Therapeutics' patent application relating to a needle-free skin preparation component of Symphony CGM system. The patent, entitled 'Skin Permeation Device ...